THERASONIC LITHOTRIPSY TREATMENT SYSTEM

FDA Premarket Approval P890066

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceTHERASONIC LITHOTRIPSY TREATMENT SYSTEM
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantFOCUS SURGERY, INC.
Date Received1989-12-07
Decision Date1991-12-20
PMAP890066
SupplementS
Product CodeLNS 
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address FOCUS SURGERY, INC. 1565 Barber Ln. milpitas, CA 95035

Supplemental Filings

Supplement NumberDateSupplement Type
P890066Original Filing
S005 1994-02-15 Normal 180 Day Track
S004 1992-03-10 Normal 180 Day Track
S003 1991-11-19 Normal 180 Day Track
S002
S001 1991-10-24 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.